These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 33108950)
1. Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease. Cummings J J Neuropsychiatry Clin Neurosci; 2021; 33(1):3-13. PubMed ID: 33108950 [TBL] [Abstract][Full Text] [Related]
2. New approaches to symptomatic treatments for Alzheimer's disease. Cummings J Mol Neurodegener; 2021 Jan; 16(1):2. PubMed ID: 33441154 [TBL] [Abstract][Full Text] [Related]
3. Behavioral outcomes in clinical trials for Alzheimer disease. Ferris SH; Mackell JA Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267 [TBL] [Abstract][Full Text] [Related]
4. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease. Cummings J; Zhong K Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713 [TBL] [Abstract][Full Text] [Related]
5. Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J; Ritter A; Zhong K J Alzheimers Dis; 2018; 64(s1):S3-S22. PubMed ID: 29562511 [TBL] [Abstract][Full Text] [Related]
6. The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist. Flint AJ; van Reekum R Can J Psychiatry; 1998 Sep; 43(7):689-97. PubMed ID: 9773218 [TBL] [Abstract][Full Text] [Related]
8. The Role of Biomarkers in Alzheimer's Disease Drug Development. Cummings J Adv Exp Med Biol; 2019; 1118():29-61. PubMed ID: 30747416 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease drug development pipeline: 2022. Cummings J; Lee G; Nahed P; Kambar MEZN; Zhong K; Fonseca J; Taghva K Alzheimers Dement (N Y); 2022; 8(1):e12295. PubMed ID: 35516416 [TBL] [Abstract][Full Text] [Related]
17. Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study. Cutler NR; Sramek JJ Eur J Clin Pharmacol; 1995; 48(6):421-8. PubMed ID: 8582458 [TBL] [Abstract][Full Text] [Related]
18. Clinical trials in predementia stages of Alzheimer disease. Pillai JA; Cummings JL Med Clin North Am; 2013 May; 97(3):439-57. PubMed ID: 23642580 [TBL] [Abstract][Full Text] [Related]
19. Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options. Cummings JL; Tong G; Ballard C J Alzheimers Dis; 2019; 67(3):779-794. PubMed ID: 30689575 [TBL] [Abstract][Full Text] [Related]
20. Use of Pharmacogenomics and Biomarkers in the Development of New Drugs for Alzheimer Disease in Japan. Otsubo Y Clin Ther; 2015 Aug; 37(8):1627-31. PubMed ID: 25963998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]